2022914
PR Heartseed recognized as the "Most Promising Pipelines (iPSC Therapy) Award" at the APAC Cell and Gene Therapy Excellent Awards 2022.
2021810
PR Heartseed named "Ministry of Education, Culture, Sports, Science and Technology (MEXT) Award" at Academic Startups 2021
202161
PR Heartseed and Novo Nordisk enter into global collaboration and licence agreement for stem cell-based therapy for heart failure
2021323
PR Heartseed Initiates Ph1/2 Clinical Trial of iPSC-derived Cardiomyocyte Spheroids (LAPiS Study) in Japan